PfuntnerA., WierL.M., StocksC.. Most Frequent Procedures Performed in U.S. Hospitals, 2010.Rockville, MD: Agency for Healthcare Research and Quality; 2013. http://hcup-us.ahrq.gov/reports/statbriefs/sb149.pdf. Accessed November 25, 2014.
2.
ShanderA., KnightK., ThurerR.. Prevalence and outcomes of anemia in surgery: a systematic review of the literature.Am J Med.2004; g116(suppl 7A): 58S–69S.
3.
TasF., EralpY., BasaranM.. Anemia in oncology practice: relation to diseases and their therapies.Am J Clin Oncol.2002; 25(4): 371–379.
ZouS., StramerS.L., DoddR.Y.. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations.Transfus Med Rev.2012; 26(2): 119–128.
6.
StramerS.L.. Tibor Greenwalt memorial award and lectureship: getting to 1 in a million and beyond. Paper presented at: AABB Annual Meeting; Philadelpha, PA; October 25-28, 2014
7.
BuschM.P., YoungM.J., SamsonS.M.; Transfusion Safety Study Group. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening.Transfusion.1991; 31(1): 4–11.
8.
WandtH., Schaefer-EckartK., WendelinK.. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.Lancet.2012; 380(9850): 1309–1316.
9.
StanworthS.J., EstcourtL.J., LlewelynC.A.. Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial (CME).Transfusion.2014; 54(10): 2385–2393.
10.
CallumJ.L., WatersJ.H., ShazB.H.. The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine.Transfusion.2014; 54(9): 2344–2352.
